Detalles de la búsqueda
1.
Dendritic cell therapy with CD137L-DC-EBV-VAX in locally recurrent or metastatic nasopharyngeal carcinoma is safe and confers clinical benefit.
Cancer Immunol Immunother
; 71(6): 1531-1543, 2022 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-34661709
2.
Immune checkpoint inhibitor combinations-current and emerging strategies.
Br J Cancer
; 128(8): 1415-1417, 2023 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-36747017
3.
The Role of Immunotherapy in the Treatment of Advanced Cervical Cancer: Current Status and Future Perspectives.
J Clin Med
; 10(19)2021 Sep 29.
Artículo
en Inglés
| MEDLINE | ID: mdl-34640541
4.
Resistance to immune checkpoint inhibitors in non-small cell lung cancer: biomarkers and therapeutic strategies.
Ther Adv Med Oncol
; 12: 1758835920937902, 2020.
Artículo
en Inglés
| MEDLINE | ID: mdl-32670423
5.
The evolving immuno-oncology landscape in advanced lung cancer: first-line treatment of non-small cell lung cancer.
Ther Adv Med Oncol
; 11: 1758835919870360, 2019.
Artículo
en Inglés
| MEDLINE | ID: mdl-31497071
6.
Anti-inflammatory Trained Immunity Mediated by Helminth Products Attenuates the Induction of T Cell-Mediated Autoimmune Disease.
Front Immunol
; 10: 1109, 2019.
Artículo
en Inglés
| MEDLINE | ID: mdl-31178861
7.
The KEY to the end of the chemotherapy in advanced non-small cell lung cancer, or not yet?
Transl Lung Cancer Res
; 8(5): 731-737, 2019 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-31737512
Resultados
1 -
7
de 7
1
Próxima >
>>